Early induction of IL-1 receptor antagonist (IL-1Ra) in infants and children undergoing surgery

Clinical and Experimental Immunology

Volumn 93, Issue 2, 1993, Pages 218-222

  O Nuallain, E M ^a   Puri, P ^a   Reen, D J ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

IL 1Ra; IL 1 ; IL 6; surgery; TNF

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ETIOLOGY; HUMAN; INFANT; INJURY; PRIORITY JOURNAL; SURGERY; SURGICAL STRESS;

EID: 0027184780     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1993.tb07969.x     Document Type: Article

References (39)

1. Br Med Bull Buckingham 41 203 1985 10.1093/oxfordjournals.bmb.a072052 Hypothalamo-pituitary response to trauma
2. Anesthesiology Weissman 73 308 1990 10.1097/00000542-199008000-00020 The metabolic response to stress: an overview and update
3. Surg Gynecol Obstet Fong 170 363 1990 The biologic characteristics of cytokines and their implication in surgical injury
4. Scand J Immunol Waage 28 267 1988 TNF, IL-1 and IL-6 in human septic shock
5. N Eng J Med Girardin 319 397 1988 10.1056/NEJM198808183190703 Tumour necrosis factor and interleukin-l in the serum of children with severe infectious purpura
6. J Pediatr Sullivan 120 510 1992 10.1016/S0022-3476(05)82476-X Correlation of plasma cytokine elevations with mortality rate in children with sepsis
7. J Clin Invest Okusawa 81 1162 1988 10.1172/JCI113431 Interleukin 1 induces a shock-like state in rabbits. Synergism with tumour necrosis factor and the effect of cyclooxygenase inhibition
8. J Exp Med Waage 167 1987 1988 10.1084/jem.167.6.1987 Interleukin 1 potentiates the lethal effect of tumour necrosis factor/cachectin in mice
9. J Rheumatol Dayer 18 71 1991 Chronic inflammatory joint diseases: natural inhibitors of interleukin 1 and tumour necrosis factor α
10. Immunol Today Larrick 10 61 1989 10.1016/0167-5699(89)90308-3 Native interleukin 1 inhibitors
11. J Biol Chem Seckinger 264 11966 1989 10.1016/S0021-9258(18)80161-2 Purification and biological characterization of a specific tumour necrosis factor α inhibitor
12. Blood Dinarello 77 1627 1991 10.1182/blood.V77.8.1627.1627 Interleukin-l and interleukin-l antagonism
13. Proc Natl Acad Sci USA Eisenberg 88 5232 1991 10.1073/pnas.88.12.5232 Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism
14. J Biol Chem Granowitz 266 14147 1991 10.1016/S0021-9258(18)98655-2 Interleukin-l receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor
15. J Biol Chem Dripps 266 10331 1991 10.1016/S0021-9258(18)99230-6 Effect of IL-1 Ra on IL-1 signal transduction
16. Cytokine Henderson 3 246 1991 10.1016/1043-4666(91)90023-7 Inhibition of interleukin-l induced synovitis and articular cartilage proteoglyclan loss in the rabbit knee by recombinant human intcrleukin-1 receptor antagonist
17. Surgery Alexander 112 188 1992 Recombinant interleukin-l receptor antagonist (IL-1 Ra): effective therapy against gram-negative sepsis in rats
18. Gastroenterology Cominelli 103 5 1992 10.1016/0016-5085(92)91096-M Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis
19. J Immunol Methods Malyak 140 281 1991 10.1016/0022-1759(91)90381-O IL-IRa ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors
20. Lancet Granowitz 338 1423 1991 10.1016/0140-6736(91)92725-H Production of interleukin-1-receptor antagonist during experimental endotoxaemia
21. Blood Fischer 79 2196 1992 10.1182/blood.V79.9.2196.2196 Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease
22. Lancet Gruss 340 968 1992 10.1016/0140-6736(92)92849-B High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease
23. J Pediatr Surg Sweed 27 1033 1992 10.1016/0022-3468(92)90553-J Early induction of IL-6 in infants undergoing major abdominal surgery
24. Lympokine Res Shenkin 8 123 1989 The serum interleukin 6 response to elective surgery
25. Lymphokine Cytokine Reg Baigrie 10 253 1991 The release of interleukin-1β(IL-1) precedes that of interleukin 6 (IL-6) in patients undergoing major surgery
26. Clin Immunol Immunopath Nishimoto 50 399 1989 10.1016/0090-1229(89)90147-5 Elevation of serum IL-6 prior to acute phase proteins on the inflammation by surgical operation
27. Immunol Invest Murata 19 271 1990 10.3109/08820139009041842 Serum interleukin 6, C-reactive protein and pancreatic secretory trypsin inhibitor (PSTI) as acute phase reactants after major thoraco-abdominal surgery
28. J Clin Invest Fischer 89 1551 1992 10.1172/JCI115748 Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia
29. J Exp Med McIntyre 173 931 1991 10.1084/jem.173.4.931 Inhibition of inlerleukin-1 (IL-1) and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody
30. Surg Gynecol Obstet Kelley 161 332 1985 Colonoscopy related endotoxemia
31. N Engl J Med Michie 318 1481 1988 10.1056/NEJM198806093182301 Detection of circulating tumour necrosis factor after endotoxin administration
32. J Clin Invest Spinas 90 533 1992 10.1172/JCI115891 Release of soluble receptors for tumour necrosis factor in relation to circulating TNF during experimental endotoxinemia
33. Trauma, stress and immunity in anaesthesia and surgery Salo 211 1982
34. Immunol Today Green 9 253 1988 10.1016/0167-5699(88)91300-X Trauma and the immune response
35. Scand J Immunol Conti 36 27 1992 10.1111/j.1365-3083.1992.tb02937.x Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1Ra)
36. Cytokine Nicod 4 29 1992 10.1016/1043-4666(92)90033-N Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens. soluble antigens or allogeneic determinants
37. J Immunol Faherty 148 766 1992 Failure of IL-1 receptor antagonist and monoclonal anti-IL-1 receptor antibody to inhibit antigen-specific immune responses in vivo
38. Cytokine Granowitz 4 353 1992 10.1016/1043-4666(92)90078-6 Pharmacokinetics. safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans
39. Immunol Rev Dinarello 127 119 1992 10.1111/j.1600-065X.1992.tb01411.x Role of interleukin-1 in infectious diseases